Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer

Jose Baselga; Mario Campone; J THADDEUS BECK; Yoshinori Ito; Denise Yardley; Ines Deleu; Alejandra Perez; Thomas Bachelot; Luc Vittori; ZHIYING XU; Pabak Mukhopadhyay; David Lebwohl; Martine Piccart; Gabriel N Hortobagyi; Howard A Burris; Hope S Rugo; Tarek Sahmoud; Shinzaburo Noguchi; Michael Gnant; Kathleen I Pritchard; Fabienne Lebrun

doi:10.1056/NEJMoa1109653

Back

Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer

Journal article

Open access

Peer reviewed

Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer

Jose Baselga, Mario Campone, J THADDEUS BECK, Yoshinori Ito, Denise Yardley, Ines Deleu, Alejandra Perez, Thomas Bachelot, Luc Vittori, ZHIYING XU, …

The New England journal of medicine, Vol.366(6), pp.520-529

2012

DOI: https://doi.org/10.1056/NEJMoa1109653

PMCID: PMC5705195

PMID: 22149876

Abstract

Antibacterial agents

Antibiotics. Antiinfectious agents. Antiparasitic agents

Biological and medical sciences

General aspects

Gynecology. Andrology. Obstetrics

Mammary gland diseases

Medical sciences

Pharmacology. Drug treatments

Tumors

Files and links (1)

url

https://doi.org/10.1056/NEJMoa1109653View

Published (Version of record) Open

Metrics

42 Record Views

2196 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.25 Molecular & Cell Biology - Cancer, Autophagy & Apoptosis; 1.25.803 mTOR
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Creators: Jose Baselga - Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, United States
Mario Campone - Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France
J THADDEUS BECK - Highlands Oncology Group, Fayetteville, AR, United States
Yoshinori Ito - Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan
Denise Yardley - Sarah Cannon Research Institute, Nashville, United States
Ines Deleu - Oncology Center, AZ Nikolass, Sint-Niklaas, Belgium, United States
Alejandra Perez - Memorial Cancer Institute, Hollywood, FL, United States
Thomas Bachelot - Centre Léon-Bérard, Lyon, France
Luc Vittori - Novartis Pharma, Basel, Switzerland
ZHIYING XU - Novartis, East Hanover, NJ, United States
Pabak Mukhopadhyay - Novartis, East Hanover, NJ, United States
David Lebwohl - Novartis, East Hanover, NJ, United States
Martine Piccart - Institute Jules Bordet, Brussels, Belgium
Gabriel N Hortobagyi - University of Texas M.D. Anderson Cancer Center, Houston, United States
Howard A Burris - Sarah Cannon Research Institute, Nashville, United States
Hope S Rugo - Helen Diller Family Comprehensive Cancer Center, San Francisco, United States
Tarek Sahmoud - Novartis, East Hanover, NJ, United States
Shinzaburo Noguchi - Osaka University, Department of Breast and Endocrine Surgery, Osaka, Japan
Michael Gnant - Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Kathleen I Pritchard - Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada
Fabienne Lebrun - Institute Jules Bordet, Brussels, Belgium
Publication Details: The New England journal of medicine, Vol.366(6), pp.520-529
Publisher: Massachusetts Medical Society
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 22149876
PMCID: PMC5705195
Record Identifier: 991031614981902976